Cargando…

Antibiotics Modulate Chemotherapy Efficacy in Patients with Esophageal Cancer

PURPOSE: Accumulating evidence suggests that microbiota dysbiosis induced by antibiotic administration plays a crucial role in regulating the efficacy and toxicity of cancer therapy. We explored the influence of antibiotic administration on the efficacy of chemotherapy in patients with esophageal ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chensi, Lai, Ruixue, Li, Jing, Zhang, Jingjing, Zhao, Yufei, Zhang, Xiaoyun, Zhao, Yue, Guo, Zhanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323800/ https://www.ncbi.nlm.nih.gov/pubmed/32612386 http://dx.doi.org/10.2147/CMAR.S248130

Ejemplares similares

Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Zhao, Yue, et al.
Publicado: (2022)

The SNPs of mitochondrial DNA displacement loop region and mitochondrial DNA copy number associated with risk of polymyositis and dermatomyositis
por: Zhao, Yufei, et al.
Publicado: (2022)

Mitochondrial Displacement Loop Region SNPs Modify Sjögren’s Syndrome Development by Regulating Cytokines Expression in Female Patients
por: Zhao, Yufei, et al.
Publicado: (2022)

Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients
por: Zhao, Yue, et al.
Publicado: (2022)

Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers
por: Wang, Yingnan, et al.
Publicado: (2023)

Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma
por: Zhang, Ruixing, et al.
Publicado: (2010)

Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?
por: Zhang, Xiaoyun, et al.
Publicado: (2022)

Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
por: Wu, Jianhua, et al.
Publicado: (2021)

Type I collagen promotes tumor progression of integrin β1 positive gastric cancer through a BCL9L/β-catenin signaling pathway
por: Lv, Yalei, et al.
Publicado: (2021)

miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma
por: Wang, Cuiju, et al.
Publicado: (2016)

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells
por: Zhang, Cuifang, et al.
Publicado: (2022)

Correlation Between Immune-Related Adverse Events and Prognosis in Hepatocellular Carcinoma Patients Treated With Immune Checkpoint Inhibitors
por: Xu, Shuo, et al.
Publicado: (2021)

Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma
por: Peng, Li, et al.
Publicado: (2016)

Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer
por: Zhao, Yufei, et al.
Publicado: (2015)

Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis
por: Guo, Yaru, et al.
Publicado: (2022)

Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer
por: Luo, Chao, et al.
Publicado: (2022)

Clinical Evaluation of Transarterial Infusion Chemotherapy for Advanced Esophageal Cancer
por: Yin, Mei-Pan, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis
por: Wang, Jincheng, et al.
Publicado: (2022)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma
por: Huang, Yuting, et al.
Publicado: (2022)

Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma
por: Xie, Ying, et al.
Publicado: (2015)

Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis
por: Zhang, Xi, et al.
Publicado: (2021)

Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial
por: Yang, Bo, et al.
Publicado: (2022)

Analysis of PICC Based on Dysfunction Module Personalized Nursing Treatment in Chemotherapy of Advanced Esophageal Cancer
por: Zhang, Qixin, et al.
Publicado: (2021)

Clinical efficacy of irinotecan plus raltitrexed chemotherapy in refractory esophageal squamous cell cancer
por: Liu, Min, et al.
Publicado: (2020)

Advances in the Prevention and Treatment of Esophageal Stricture after Endoscopic Submucosal Dissection of Early Esophageal Cancer
por: Zhang, Yue, et al.
Publicado: (2020)

Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer
por: Zheng, Ziming, et al.
Publicado: (2022)

“Targeted” Chemotherapy for Esophageal Cancer
por: Abdo, Joe, et al.
Publicado: (2017)

Editorial: Chemotherapy in esophageal cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta‐analysis
por: Zhao, Peiliang, et al.
Publicado: (2018)

The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Zhao, Zheng, et al.
Publicado: (2023)

Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study
por: Chen, Jianzhou, et al.
Publicado: (2016)

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2020)

A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer
por: Wu, Rui, et al.
Publicado: (2021)

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer
por: Zhang, Baihua, et al.
Publicado: (2023)

Efficacy and Safety of Simultaneous Integrated Boost Intensity-Modulation Radiation Therapy Combined with Systematic and Standardized Management for Esophageal Cancer
por: Deng, Wenzhao, et al.
Publicado: (2022)

The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
por: Lu, Yanan, et al.
Publicado: (2019)

Perioperative and Palliative Chemotherapy for Esophageal Cancer
por: Behrens, Angelika, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c7pbv5doct442h7ud3njpqkqeu